Novartis: fine of 48 million in South Korea

Risultati immagini per medico della corea del sudNovartis was fined 48 million francs (Swiss, €44.33 million, ed) in South Korea for granting unauthorized discounts to doctors for prescribing his drugs.

The Seoul Ministry of Health has also suspended for six months the insurance coverage of two preparations of the Swiss group, Exelon and Zometa.

Contacted by the ats Novartis confirmed the announcement made by the Korean authorities and deplored the behavior of employees who did not comply with internal directives. Several employees of the group have been indicted in South Korea.

SDA-ATS 27 APRIL 2017 – Swiss TV

Redazione Fedaiisf

Promote the cohesion and union of all members to allow a univocal and homogeneous vision of the professional problems inherent in the activity of pharmaceutical sales reps.

Articoli correlati

Back to top button
Fedaiisf Federazione delle Associazioni Italiane degli Informatori Scientifici del Farmaco e del Parafarmaco